Sichenzia Ross Ference Carmel represented INmune Bio, Inc. in the offering.INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company, announced approximately $4.8 million registered direct offering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
